CVS Health Corporation: shareholders and insiders

CVSNYSEHealthcare · Retail-Drug Stores and Proprietary Stores

Price

$88.59

November 16, 2026Market cap $113B

What Ploutos Investor adds for CVS Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Nov 6, 2026, from their own Form 4 filings.

6 Form 4s

Bought on the market

$2.0M

1 person

Sold on the market

$324M

2 people

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 17, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $2.0M by 1 person·sold $324M by 2 people

  • 2025: no buys, no sales
  • 2026: bought $2.0M by 1 person, sold $324M by 2 people
  • Nov 6, 2026Prem S ShahEVP and Group President
    Kind
  • Jun 26, 2026James David ClarkSVP, Cont & Chief Acct Officer
    Kind
  • May 31, 2026Brian NewmanEVP, Chief Financial Officer
    Kind
  • May 31, 2026Amy Compton-PhillipsEVP, Chief Medical Officer
    Kind
  • May 21, 2026Fernando AguirreDirector
    Kind
  • May 21, 2026Larry RobbinsDirector
    Kind
  • May 20, 2026Fernando AguirreDirector
    Kind
  • May 20, 2026Larry RobbinsDirector
    Kind
  • May 20, 2026Larry RobbinsDirector
    Kind
  • May 20, 2026Larry RobbinsDirector
    Kind
  • May 20, 2026Larry RobbinsDirector
    Kind
  • May 19, 2026Larry RobbinsDirector
    Kind
  • May 19, 2026Larry RobbinsDirector
    Kind
  • May 8, 2026Tilak MandadiEVP, Chief Exp & Tech Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before May 21, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by CVS's officers and directors from 2006 up to November 16, 2025, 20 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Aug 13, 2026 Latest filing
  • BlackRock, Inc.
    Share of class8.30%
  • Vanguard Capital Management
    Share of class7.51%
  • Capital World Investors
    Share of class5.50%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Dodge & Cox3.90%Aug 13, 202613G/A
  • The Vanguard Group0.00%Mar 26, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Fairfax Financial (Watsa)
    In the quarter
  • Glenview Capital
    In the quarter-41%
  • Viking Global (Halvorsen)
    In the quarter
  • Renaissance Technologies
    In the quarter+518%
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-11%
  • Bridgewater (Dalio)
    In the quarter-29%
  • Millennium Mgmt (Englander)
    In the quarter×11.1
  • D.E. Shaw
    In the quarter-15%
  • AQR Capital
    In the quarter+1.0%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.27% of its shares outstanding were held short, -1.7% since the report before.

Shares held short
16.19M
1.27%
Since the report before16.47M on Sep 30, 2026
-1.7%
1.6
10.33M
More days to cover thanof 4,578 US-listed companies with enough volume
21%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 15.87M
  • Nov 15, 2023: Shares held short 15.84M
  • Nov 30, 2023: Shares held short 15.58M
  • Dec 15, 2023: Shares held short 14.84M
  • Dec 29, 2023: Shares held short 16.45M
  • Jan 12, 2024: Shares held short 42.52M
  • Jan 31, 2024: Shares held short 36.79M
  • Feb 15, 2024: Shares held short 30.76M
  • Feb 29, 2024: Shares held short 24.17M
  • Mar 15, 2024: Shares held short 18.64M
  • Mar 28, 2024: Shares held short 22.72M
  • Apr 15, 2024: Shares held short 18.00M
  • Apr 30, 2024: Shares held short 13.71M
  • May 15, 2024: Shares held short 11.37M
  • May 31, 2024: Shares held short 17.71M
  • Jun 14, 2024: Shares held short 20.64M
  • Jun 28, 2024: Shares held short 18.43M
  • Jul 15, 2024: Shares held short 17.82M
  • Jul 31, 2024: Shares held short 19.99M
  • Aug 15, 2024: Shares held short 17.42M
  • Aug 30, 2024: Shares held short 18.50M
  • Sep 13, 2024: Shares held short 17.40M
  • Sep 30, 2024: Shares held short 19.75M
  • Oct 15, 2024: Shares held short 20.80M
  • Oct 31, 2024: Shares held short 21.85M
  • Nov 15, 2024: Shares held short 21.39M
  • Nov 29, 2024: Shares held short 17.77M
  • Dec 13, 2024: Shares held short 19.03M
  • Dec 31, 2024: Shares held short 18.10M
  • Jan 15, 2025: Shares held short 16.99M
  • Jan 31, 2025: Shares held short 21.35M
  • Feb 14, 2025: Shares held short 23.60M
  • Feb 28, 2025: Shares held short 20.55M
  • Mar 14, 2025: Shares held short 19.88M
  • Mar 31, 2025: Shares held short 18.26M
  • Apr 15, 2025: Shares held short 18.65M
  • Apr 30, 2025: Shares held short 16.43M
  • May 15, 2025: Shares held short 15.90M
  • May 30, 2025: Shares held short 15.45M
  • Jun 13, 2025: Shares held short 18.71M
  • Jun 30, 2025: Shares held short 16.02M
  • Jul 15, 2025: Shares held short 13.67M
  • Jul 31, 2025: Shares held short 15.65M
  • Aug 15, 2025: Shares held short 16.66M
  • Aug 29, 2025: Shares held short 18.80M
  • Sep 15, 2025: Shares held short 23.62M
  • Sep 30, 2025: Shares held short 18.94M
  • Oct 15, 2025: Shares held short 19.52M
  • Oct 31, 2025: Shares held short 18.90M
  • Nov 14, 2025: Shares held short 19.29M
  • Nov 28, 2025: Shares held short 19.63M
  • Dec 15, 2025: Shares held short 22.92M
  • Dec 31, 2025: Shares held short 21.67M
  • Jan 15, 2026: Shares held short 18.76M
  • Jan 30, 2026: Shares held short 20.35M
  • Feb 13, 2026: Shares held short 16.53M
  • Feb 27, 2026: Shares held short 17.58M
  • Mar 13, 2026: Shares held short 17.81M
  • Mar 31, 2026: Shares held short 19.89M
  • Apr 15, 2026: Shares held short 18.35M
  • Apr 30, 2026: Shares held short 17.81M
  • May 15, 2026: Shares held short 19.52M
  • May 29, 2026: Shares held short 17.76M
  • Jun 15, 2026: Shares held short 23.19M
  • Jun 30, 2026: Shares held short 19.94M
  • Jul 15, 2026: Shares held short 19.52M
  • Jul 31, 2026: Shares held short 18.68M
  • Aug 14, 2026: Shares held short 16.82M
  • Aug 31, 2026: Shares held short 18.11M
  • Sep 15, 2026: Shares held short 16.12M
  • Sep 30, 2026: Shares held short 16.47M
  • Oct 15, 2026: Shares held short 16.19M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading24.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 24.5% of the shares in the reported trades were short sales, against 33.9% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
24.5%
The 14 beforeOct 8, 2026 – Oct 27, 2026
33.9%
Change
-9.4 pts
Short sales a dayon average, of 5.29M shares
1.30M
More than atof 3,668 US-listed companies, same days
2%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 22.4%
  • Oct 9, 2026: Short sales 22.9%
  • Oct 12, 2026: Short sales 21.6%
  • Oct 13, 2026: Short sales 41%
  • Oct 14, 2026: Short sales 27.1%
  • Oct 15, 2026: Short sales 22%
  • Oct 16, 2026: Short sales 35.4%
  • Oct 19, 2026: Short sales 29.6%
  • Oct 20, 2026: Short sales 58.6%
  • Oct 21, 2026: Short sales 54%
  • Oct 22, 2026: Short sales 46.5%
  • Oct 23, 2026: Short sales 48.4%
  • Oct 26, 2026: Short sales 44.3%
  • Oct 27, 2026: Short sales 39.1%
  • Oct 28, 2026: Short sales 23.1%
  • Oct 29, 2026: Short sales 10%
  • Oct 30, 2026: Short sales 20.6%
  • Nov 2, 2026: Short sales 14.9%
  • Nov 3, 2026: Short sales 17.4%
  • Nov 4, 2026: Short sales 28.2%
  • Nov 5, 2026: Short sales 12.7%
  • Nov 6, 2026: Short sales 16.5%
  • Nov 9, 2026: Short sales 23.9%
  • Nov 10, 2026: Short sales 41.2%
  • Nov 11, 2026: Short sales 45.3%
  • Nov 12, 2026: Short sales 46.8%
  • Nov 13, 2026: Short sales 31.6%
  • Nov 16, 2026: Short sales 26.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

5.07M Insiders' shares0.40% Of the company
  • Larry RobbinsDirector
    Directly–
  • Prem S ShahEVP and Pres-Pharm, Consumer W
    Directly88.5K
  • Michael F MahoneyDirector
    Directly39.4K
  • James David ClarkSVP, Cont & Chief Acct Officer
    Directly27.6K
  • Anne A. FinucaneDirector
    Directly–
  • Edward J LudwigDirector
    Directly21.6K
  • Guy P SansoneDirector
    Directly12.0K
  • Fernando AguirreDirector
    Directly10.5K
  • Tilak MandadiEVP, Chief Exp & Tech Officer
    Directly10.1K
  • Amy Compton-PhillipsEVP, Chief Medical Officer
    Directly9,557
  • Brian NewmanEVP, Chief Financial Officer
    Directly3,008
  • Heidi B CapozziEVP and Chief People Officer
    Directly–
  • Steven H NelsonEVP and President, Aetna
    Directly–

A lower bound: it counts only the 13 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Executive pay

From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.

2025 Latest year6 Years on record

$21M

Actually paid: $50M

$10M

Actually paid: $17M

$137

Peers: $148

Adjusted Earnings Per Share

From the proxy statement (DEF 14A) of Apr 3, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A

Share repurchases

How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.

– Repurchases over 4 quarters$11.5B Left in the program
  • Jun 30, 202610-Q
    Amount–
  • Mar 31, 202610-Q
    Amount–
  • Sep 30, 202510-Q
    Amount–
  • Jun 30, 202510-Q
    Amount–
  • Mar 31, 202510-Q
    Amount–
  • Sep 30, 202410-Q
    Amount–
  • Jun 30, 202410-Q
    Amount–
  • Mar 31, 202410-Q
    Amount$3.0B

From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

42 ETFs holding it2.30% The largest weight (XLV)
  • XLVState Street(R) Health Care Select Sector SPDR(R) ETF
    Weight in the fund2.30%
  • IXJiShares Global Healthcare ETF
    Weight in the fund1.71%
  • VHTVanguard Health Care Index Fund
    Weight in the fund1.65%
  • VLUEiShares MSCI USA Value Factor ETF
    Weight in the fund1.54%
  • SPYDState Street(R) SPDR(R) Portfolio S&P 500(R) High Dividend ETF
    Weight in the fund1.52%
  • DVYiShares Select Dividend ETF
    Weight in the fund1.49%
  • CGUSCapital Group Core Equity ETF
    Weight in the fund0.87%
  • FNDXSchwab Fundamental U.S. Large Company ETF
    Weight in the fund0.79%
  • MGVVanguard Morningstar Mega Cap Value Index Fund
    Weight in the fund0.55%
  • VYMVanguard High Dividend Yield Index Fund
    Weight in the fund0.54%

42 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

2,069 Managers, Q2 2026$118B Value of their positions
  • Q3 2025: Managers 1,841
  • Q4 2025: Managers 1,951
  • Q1 2026: Managers 1,883
  • Q2 2026: Managers 2,069

Institutional investors by quarter

The fund managers holding CVS, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 2,069 managers held 1.14B shares, worth $118B. During the quarter 320 opened a position, 134 closed one, 757 added and 726 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter-2.1%
  • Vanguard Capital Management
    In the quarter+0.8%
  • Capital World Investors
    In the quarter-3.0%
  • State Street
    In the quarter+1.6%
  • Dodge & Cox
    In the quarter-3.4%
  • Wellington Management Group
    In the quarter+50%
  • Geode Capital Management
    In the quarter+1.5%
  • FMR
    In the quarter-7.3%
  • Vanguard Portfolio Management
    In the quarter+2.5%
  • Capital Research Global Investors
    In the quarter+22%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

The full analysis

What do CVS Health's filings show?

Who buys and sells is one part of CVS Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CVS's shareholders

Didn't find what you were looking for?

Ask us
Have CVS's insiders bought or sold?

From May 21, 2026 to Nov 6, 2026 CVS Health's insiders bought $2.0M and sold $317M of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold CVS?

10 of the managers we track held the shares on Sep 30, 2026. The largest position was Glenview Capital's, worth $499M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.